Document Detail


Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment.
MedLine Citation:
PMID:  10446117     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Data on meconium bile acid composition in newborn babies of patients with intrahepatic cholestasis of pregnancy (ICP) are relatively scant, and changes that occur on ursodeoxycholic acid (UDCA) administration have not been evaluated. AIMS: To investigate bile acid profiles in meconium of neonates from untreated and UDCA treated patients with ICP. Maternal serum bile acid composition was also analysed both at diagnosis and delivery to determine whether this influences the concentration and proportion of bile acids in the meconium. PATIENTS/METHODS: The population included eight healthy pregnant women and 16 patients with ICP, nine of which received UDCA (12.5-15.0 mg/kg body weight/day) for 15+/-4 days until parturition. Bile acids were assessed in the meconium by gas chromatography-mass spectrometry and in maternal serum by high performance liquid chromatography. RESULTS: Total bile acid and cholic acid concentrations in the meconium were increased (p<0.01) in newborns from patients with ICP (13.5 (5.1) and 8.4 (4.1) micromol/g respectively; mean (SEM)) as compared with controls (2.0 (0.5) and 0.8 (0.3) micromol/g respectively), reflecting the total bile acid and cholic acid levels in the maternal serum (r = 0.85 and r = 0.84, p<0.01). After UDCA administration, total bile acid concentrations decreased in the mother ( approximately 3-fold, p<0. 05) but not in the meconium. UDCA concentration in the meconium showed only a 2-fold increase after treatment, despite the much greater increase in the maternal serum (p<0.01). Lithocholic acid concentration in the meconium was not increased by UDCA treatment. CONCLUSIONS: UDCA administration does not influence the concentration and proportion of bile acids in the meconium, which in turn are altered by ICP. Moreover, this beneficial treatment for the mother does not increase meconium levels of potentially toxic metabolites of UDCA such as lithocholic acid.
Authors:
C M Rodrigues; J J Marín; D Brites
Related Documents :
3071137 - Treatment of uremic hyperphosphatemia--is there still a need for aluminum salts?
18155707 - Substitution of aspartic acid at position 57 of the dqbeta1 affects relapse of autoimmu...
10994627 - Is the increase in serum cystathionine levels in patients with liver cirrhosis a conseq...
15831907 - Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria,...
24023657 - Induction of porcine host defense peptide gene expression by short-chain fatty acids an...
2875687 - Hepatic metabolism of dietary alpha-linolenic acid in suckling rats, and its possible i...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Gut     Volume:  45     ISSN:  0017-5749     ISO Abbreviation:  Gut     Publication Date:  1999 Sep 
Date Detail:
Created Date:  1999-09-28     Completed Date:  1999-09-28     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  2985108R     Medline TA:  Gut     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  446-52     Citation Subset:  AIM; IM    
Affiliation:
Centro de Patogénese Molecular, Faculdade de Farmácia, University of Lisbon, Portugal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bile Acids and Salts / blood,  metabolism*
Cholagogues and Choleretics / therapeutic use*
Cholestasis, Intrahepatic / drug therapy,  metabolism*
Cholic Acid / blood,  metabolism
Female
Humans
Infant, Newborn
Maternal-Fetal Exchange
Meconium / metabolism*
Pregnancy
Pregnancy Complications / drug therapy,  metabolism*
Ursodeoxycholic Acid / therapeutic use*
Chemical
Reg. No./Substance:
0/Bile Acids and Salts; 0/Cholagogues and Choleretics; 128-13-2/Ursodeoxycholic Acid; 81-25-4/Cholic Acid
Comments/Corrections
Comment In:
Gut. 1999 Sep;45(3):331-2   [PMID:  10446097 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hepatic manifestations of familial patent ductus venosus in adults.
Next Document:  The effects of short term lipid infusion on plasma and hepatic bile lipids in humans.